IgA nephropathy (IGAN)
Clinical trials for IgA nephropathy (IGAN) explained in plain language.
Never miss a new study
Get alerted when new IgA nephropathy (IGAN) trials appear
Sign up with your email to follow new studies for IgA nephropathy (IGAN), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a single injection drug calm the immune attack on kidneys?
Disease control OngoingThis phase 2 trial tests an experimental drug called SGB-9768 in adults with three related kidney diseases: IgA nephropathy, C3 glomerulopathy, and immune complex-mediated membranoproliferative glomerulonephritis. These conditions occur when the immune system deposits proteins in…
Matched conditions: IGA NEPHROPATHY (IGAN)
Phase 2 • Sponsor: Suzhou Sanegene Bio Inc. • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Can an Anti-Inflammatory diet protect the kidneys? a trial puts the autoimmune protocol to the test
Disease control CancelledThis UCLA study is testing whether the Autoimmune Protocol (AIP) diet — which avoids dairy, grains, and sugar — can reduce protein levels in the urine of people with IgA nephropathy, a kidney disease that can lead to kidney failure. Thirty adults aged 18 to 65 with active disease…
Matched conditions: IGA NEPHROPATHY (IGAN)
Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Atacicept's Long-Term promise for kidney disease
Disease control By invitation onlyThis study looks at the long-term safety and effects of atacicept in people with IgA nephropathy, a kidney disease. Participants have already completed a previous trial with atacicept. Researchers will monitor side effects and measure kidney function over time to see if the drug …
Matched conditions: IGA NEPHROPATHY (IGAN)
Phase 2 • Sponsor: Vera Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New monthly shot could tame rare kidney disease
Disease control OngoingThis study tests a drug called atacicept given once a month to people with IgA nephropathy, a kidney disease that can lead to kidney failure. The goal is to see if monthly dosing lowers harmful antibodies and reduces protein in the urine, which are signs of kidney damage. About 9…
Matched conditions: IGA NEPHROPATHY (IGAN)
Phase 2 • Sponsor: Vera Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Can AI learn to spot kidney disease in biopsy images?
Diagnosis OngoingResearchers are building deep learning models that analyze digital images of kidney biopsy tissue to classify kidney diseases such as IgA nephropathy and membranous nephropathy. The study uses pathology images and clinical data from thousands of patients who had kidney biopsies a…
Matched conditions: IGA NEPHROPATHY (IGAN)
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Diagnosis
Last updated Sep 16, 2026 00:00 UTC